← Open Payments lookup

NEIL KAHN: Open Payments

NPI 1831190602 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,278 in 111 payments from 15 companies in 2025. Trend: 2023 $1,722 · 2024 $2,025 · 2025 $2,278

Food & beverage: $2,198Education: $80
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.23$347
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$331
E.R. Squibb & Sons, L.L.C.10$298
Neurocrine BioSciences, Inc.11$241
Alkermes, Inc.12$239
Teva Pharmaceuticals USA, Inc.5$168
Janssen Pharmaceuticals, Inc7$158
Takeda Pharmaceuticals U.S.A., Inc.9$143
Lundbeck LLC6$125
Axsome Therapeutics, Inc.3$72

Products named: REXULTI, CAPLYTA, COBENFY, INGREZZA, ARISTADA, TRINTELLIX, SPRAVATO, Auvelity.

Industry payments across GA — which companies pay providers there.